PAEEX | RIDAX | PAEEX / RIDAX | |
Total Expense Ratio | 0.68 | 1.36 | 50% |
Annual Report Gross Expense Ratio | 0.68 | 1.36 | 50% |
Fund Existence | 13 years | 23 years | - |
Gain YTD | -9.656 | -2.920 | 331% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.39B | 121B | 2% |
Annual Yield % from dividends | 2.19 | 3.12 | 70% |
Returns for 1 year | -8.95 | 1.42 | -631% |
Returns for 3 years | 4.17 | -0.58 | -723% |
Returns for 5 years | 35.26 | 30.74 | 115% |
Returns for 10 years | 23.92 | 21.51 | 111% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PUFCX | 16.73 | 0.03 | +0.18% |
PGIM Jennison Financial Services C | |||
GSMAX | 16.55 | N/A | N/A |
Goldman Sachs Small/Mid Cap Growth A | |||
INGFX | 29.78 | N/A | N/A |
Invesco Oppenheimer International Gr R5 | |||
SHPCX | 12.42 | N/A | N/A |
Saratoga Health & Biotechnology C | |||
NFJEX | 9.24 | -0.13 | -1.39% |
Virtus NFJ Dividend Value Inst |